Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | HTT | P42858 | 3/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | USP2 | O75604 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.74 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.74 |
| ▸ | RGS12 | O14924 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | ATM | Q13315 | 1/20 | 0.74 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.68 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.68 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.68 |
| ▸ | FLT4 | P35916 | 1/20 | 0.68 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372370 | 0.85 | KMT2A (1.00) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL29460431 | 0.85 | KMT2A (1.00) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL19718354 | 0.84 | KMT2A (0.86) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL7523337 | 0.82 | KMT2A (0.84) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL1505179 | 0.82 | KMT2A (0.88) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL7524308 | 0.82 | KMT2A (0.69) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL7153098 | 0.82 | DYRK3 (0.71) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL14817833 | 0.81 | KMT2A (0.82) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL7521157 | 0.81 | DYRK3 (0.71) | KMT2AMAPTHTTMEN1USP2 | |
| SCHEMBL8397978 | 0.81 | KMT2A (0.86) | KMT2AMAPTHTTMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213232-A1 | BIOHYBRID PEPTIDOGLYCAN OLIGOMERS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213232-A1 | BIOHYBRID PEPTIDOGLYCAN OLIGOMERS | NOD2, DDOST, CD14 | KMT2A 4840/4885MAPT 1730/4885HTT 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.